These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

57 related items for PubMed ID: 1823387

  • 1. 125I-vasoactive intestinal peptide binding in human kidney.
    Charlton BG, Neal DE, Simmons NL.
    Miner Electrolyte Metab; 1991; 17(6):372-6. PubMed ID: 1823387
    [Abstract] [Full Text] [Related]

  • 2. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [Abstract] [Full Text] [Related]

  • 3. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Pol J Pharmacol; 2004 Jun; 56(2):203-11. PubMed ID: 15156071
    [Abstract] [Full Text] [Related]

  • 4. Modifications of the binding properties of the human VIP receptor of IGR39 cells by sulfhydryl reagents.
    Fouchier F, Forget P, Pic P, Marvaldi J, Pichon J.
    Eur J Cell Biol; 1992 Dec; 59(2):382-8. PubMed ID: 1337321
    [Abstract] [Full Text] [Related]

  • 5. Localisation and characterisation of functional vasoactive intestinal peptide receptors in feline kidney.
    Griffiths NM, Simmons NL.
    Pflugers Arch; 1990 Apr; 416(1-2):80-7. PubMed ID: 2162036
    [Abstract] [Full Text] [Related]

  • 6. Identification of high affinity receptors for vasoactive intestinal peptide on human lymphocytes of B cell lineage.
    O'Dorisio MS, Shannon BT, Fleshman DJ, Campolito LB.
    J Immunol; 1989 May 15; 142(10):3533-6. PubMed ID: 2541199
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the vasoactive intestinal peptide receptor in rat submandibular gland: radioligand binding assay in membrane preparations.
    Turner JT, Bylund DB.
    J Pharmacol Exp Ther; 1987 Sep 15; 242(3):873-81. PubMed ID: 2821229
    [Abstract] [Full Text] [Related]

  • 8. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
    Laburthe M, Couvineau A, Rouyer-Fessard C.
    Mol Pharmacol; 1986 Jan 15; 29(1):23-7. PubMed ID: 3003561
    [Abstract] [Full Text] [Related]

  • 9. Direct evidence for functional coupling of the vasoactive intestinal peptide receptor to Gi3 in native lung membranes.
    Diehl NL, Kermode JC, Shreeve SM.
    Mol Pharmacol; 1996 Sep 15; 50(3):624-30. PubMed ID: 8794903
    [Abstract] [Full Text] [Related]

  • 10. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
    Mittag TW, Tormay A, Podos SM.
    J Pharmacol Exp Ther; 1987 Apr 15; 241(1):230-5. PubMed ID: 3033201
    [Abstract] [Full Text] [Related]

  • 11. Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68.
    Van Valen F, Jürgens H, Winkelmann W, Keck E.
    Cell Signal; 1989 Apr 15; 1(5):435-46. PubMed ID: 2561912
    [Abstract] [Full Text] [Related]

  • 12. Recognition of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide (PACAP/VIP) hybrids and related peptides by rat brain membranes.
    Ando E, Nokihara K, Naruse S, Wray V.
    Biomed Pept Proteins Nucleic Acids; 1996 Apr 15; 2(2):41-6. PubMed ID: 9346825
    [Abstract] [Full Text] [Related]

  • 13. Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung.
    Carstairs JR, Barnes PJ.
    J Pharmacol Exp Ther; 1986 Oct 15; 239(1):249-55. PubMed ID: 3020233
    [Abstract] [Full Text] [Related]

  • 14. Vasoactive intestinal peptide stimulation of human renal adenylate cyclase in vitro.
    Charlton BG, Neal DE, Simmons NL.
    J Physiol; 1990 Apr 15; 423():475-84. PubMed ID: 2167366
    [Abstract] [Full Text] [Related]

  • 15. High affinity receptors for vasoactive intestinal peptide on a human glioma cell line.
    Nielsen FC, Gammeltoft S, Westermark B, Fahrenkrug J.
    Peptides; 1990 Apr 15; 11(6):1225-31. PubMed ID: 1965033
    [Abstract] [Full Text] [Related]

  • 16. Autoradiographic mapping of [mono[125I]iodo-Tyr10, MetO17]vasoactive intestinal peptide binding sites in the rat brain.
    Martin JL, Dietl MM, Hof PR, Palacios JM, Magistretti PJ.
    Neuroscience; 1987 Nov 15; 23(2):539-65. PubMed ID: 3437978
    [Abstract] [Full Text] [Related]

  • 17. Vasoactive intestinal peptide control of renal adenylate cyclase: in vitro studies of canine renal membranes and cultured canine renal epithelial (MDCK) cells.
    Griffiths NM, Rugg EL, Simmons NL.
    Q J Exp Physiol; 1989 May 15; 74(3):339-53. PubMed ID: 2546173
    [Abstract] [Full Text] [Related]

  • 18. High-affinity binding sites for VIP in renal cortical membranes: possible role of VIP in renal transport.
    Kniaz D, Pahlavan P, Valaitis D, Arruda JA.
    Kidney Int; 1991 Feb 15; 39(2):266-72. PubMed ID: 1848330
    [Abstract] [Full Text] [Related]

  • 19. An endothelial cell-line contains functional vasoactive intestinal polypeptide receptors: they control inwardly rectifying K+ channels.
    Pasyk E, Mao YK, Ahmad S, Shen SH, Daniel EE.
    Eur J Pharmacol; 1992 Mar 03; 212(2-3):209-14. PubMed ID: 1318211
    [Abstract] [Full Text] [Related]

  • 20. Autoradiographic localisation of VIP receptors in human lung.
    Leys K, Morice AH, Madonna O, Sever PS.
    FEBS Lett; 1986 Apr 21; 199(2):198-202. PubMed ID: 3009219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.